CN1323700C - 一种治疗虚损病的中药组合物及其制备方法和质量标准 - Google Patents
一种治疗虚损病的中药组合物及其制备方法和质量标准 Download PDFInfo
- Publication number
- CN1323700C CN1323700C CNB2004100691311A CN200410069131A CN1323700C CN 1323700 C CN1323700 C CN 1323700C CN B2004100691311 A CNB2004100691311 A CN B2004100691311A CN 200410069131 A CN200410069131 A CN 200410069131A CN 1323700 C CN1323700 C CN 1323700C
- Authority
- CN
- China
- Prior art keywords
- solution
- water
- methanol
- dryness
- weight portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 32
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 208000027219 Deficiency disease Diseases 0.000 title 1
- 238000012360 testing method Methods 0.000 claims abstract description 80
- 238000000034 method Methods 0.000 claims abstract description 41
- 241001550206 Colla Species 0.000 claims abstract description 31
- 210000000582 semen Anatomy 0.000 claims abstract description 31
- 239000000463 material Substances 0.000 claims abstract description 22
- 238000004809 thin layer chromatography Methods 0.000 claims abstract description 21
- 239000009636 Huang Qi Substances 0.000 claims abstract description 18
- 241000209020 Cornus Species 0.000 claims abstract description 16
- 238000001035 drying Methods 0.000 claims abstract description 9
- 238000003908 quality control method Methods 0.000 claims abstract description 7
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 6
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 5
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 5
- 235000011477 liquorice Nutrition 0.000 claims abstract description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 180
- 239000000243 solution Substances 0.000 claims description 114
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 108
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 53
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 52
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 42
- 239000013558 reference substance Substances 0.000 claims description 38
- 239000007788 liquid Substances 0.000 claims description 30
- TZJALUIVHRYQQB-XFDQAQKOSA-N Icariin Natural products O(C)c1ccc(C2=C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)C(=O)c3c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)c(C/C=C(\C)/C)c3O2)cc1 TZJALUIVHRYQQB-XFDQAQKOSA-N 0.000 claims description 28
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 claims description 28
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 claims description 28
- 239000000706 filtrate Substances 0.000 claims description 23
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 22
- 239000003480 eluent Substances 0.000 claims description 19
- 239000002904 solvent Substances 0.000 claims description 18
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 16
- 230000007935 neutral effect Effects 0.000 claims description 16
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 15
- 239000000047 product Substances 0.000 claims description 14
- 238000010992 reflux Methods 0.000 claims description 14
- 239000011248 coating agent Substances 0.000 claims description 13
- 238000000576 coating method Methods 0.000 claims description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 229940079593 drug Drugs 0.000 claims description 12
- 239000000741 silica gel Substances 0.000 claims description 12
- 229910002027 silica gel Inorganic materials 0.000 claims description 12
- 238000003556 assay Methods 0.000 claims description 11
- 239000000284 extract Substances 0.000 claims description 10
- 239000008194 pharmaceutical composition Substances 0.000 claims description 10
- 239000012567 medical material Substances 0.000 claims description 9
- 239000007921 spray Substances 0.000 claims description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 8
- 229960000583 acetic acid Drugs 0.000 claims description 8
- 239000012362 glacial acetic acid Substances 0.000 claims description 8
- 239000004952 Polyamide Substances 0.000 claims description 6
- 238000003810 ethyl acetate extraction Methods 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 229920002647 polyamide Polymers 0.000 claims description 6
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 claims description 5
- 238000001514 detection method Methods 0.000 claims description 5
- 238000001704 evaporation Methods 0.000 claims description 5
- 239000000945 filler Substances 0.000 claims description 5
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 5
- 239000000377 silicon dioxide Substances 0.000 claims description 5
- 238000011003 system suitability test Methods 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 claims description 4
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000010282 Emodin Substances 0.000 claims description 4
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 claims description 4
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 claims description 4
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 claims description 4
- 241000238370 Sepia Species 0.000 claims description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 4
- 229910021529 ammonia Inorganic materials 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 claims description 4
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 claims description 4
- 239000011230 binding agent Substances 0.000 claims description 4
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 claims description 4
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 claims description 4
- 239000000890 drug combination Substances 0.000 claims description 4
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 claims description 4
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 230000003760 hair shine Effects 0.000 claims description 4
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 4
- YEZWWUMWIFKEQM-UHFFFAOYSA-N O.OC.ClC(Cl)Cl.CCOC(C)=O Chemical compound O.OC.ClC(Cl)Cl.CCOC(C)=O YEZWWUMWIFKEQM-UHFFFAOYSA-N 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims 1
- 229910052782 aluminium Inorganic materials 0.000 claims 1
- 230000003647 oxidation Effects 0.000 claims 1
- 238000007254 oxidation reaction Methods 0.000 claims 1
- 230000007812 deficiency Effects 0.000 abstract description 25
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 238000001914 filtration Methods 0.000 abstract description 3
- 239000003292 glue Substances 0.000 abstract description 3
- 239000000843 powder Substances 0.000 abstract description 3
- 241001289529 Fallopia multiflora Species 0.000 abstract 2
- 238000002156 mixing Methods 0.000 abstract 2
- 238000010298 pulverizing process Methods 0.000 abstract 2
- 241001061264 Astragalus Species 0.000 abstract 1
- 241000804384 Cynomorium songaricum Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 241001278833 Rosa laevigata Species 0.000 abstract 1
- 235000000661 Rosa laevigata Nutrition 0.000 abstract 1
- 235000011034 Rubus glaucus Nutrition 0.000 abstract 1
- 244000235659 Rubus idaeus Species 0.000 abstract 1
- 235000009122 Rubus idaeus Nutrition 0.000 abstract 1
- 208000031975 Yang Deficiency Diseases 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 238000000227 grinding Methods 0.000 abstract 1
- 238000004128 high performance liquid chromatography Methods 0.000 abstract 1
- 238000005259 measurement Methods 0.000 abstract 1
- 239000006228 supernatant Substances 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 238000010025 steaming Methods 0.000 description 66
- 230000000694 effects Effects 0.000 description 13
- 208000024891 symptom Diseases 0.000 description 10
- 208000011580 syndromic disease Diseases 0.000 description 10
- 210000001835 viscera Anatomy 0.000 description 10
- 238000012850 discrimination method Methods 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 206010029446 nocturia Diseases 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 5
- 206010016256 fatigue Diseases 0.000 description 4
- 210000000629 knee joint Anatomy 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 206010024264 Lethargy Diseases 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical group O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 2
- 238000013096 assay test Methods 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000012201 sexual and gender identity disease Diseases 0.000 description 2
- 208000015891 sexual disease Diseases 0.000 description 2
- -1 stilbene glucoside Chemical class 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 1
- 206010006100 Bradykinesia Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 235000005903 Dioscorea Nutrition 0.000 description 1
- 235000000504 Dioscorea villosa Nutrition 0.000 description 1
- 244000281702 Dioscorea villosa Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- SIHHLZPXQLFPMC-UHFFFAOYSA-N chloroform;methanol;hydrate Chemical compound O.OC.ClC(Cl)Cl SIHHLZPXQLFPMC-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000010812 external standard method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- DHRLEVQXOMLTIM-UHFFFAOYSA-N phosphoric acid;trioxomolybdenum Chemical compound O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.OP(O)(O)=O DHRLEVQXOMLTIM-UHFFFAOYSA-N 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 235000019590 thick flavour Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
提取方法 | 超声处理1小时 | 加热回流1小时 |
含量(mg/粒) | 0.0875 | 0.0869 |
提取溶剂 | 50%乙醇 | 70%乙醇 | 100%乙醇 |
含量(mg/粒) | 0.0769 | 0.0826 | 0.0860 |
洗脱剂 | 60ml | 80ml | 81~100ml |
含量(mg/粒) | 0.0876 | 0.0811 | 0 |
批号 | 1 | 2 | 平均(mg/片) |
020301020302020303 | 0.07200.08430.0884 | 0.07510.08880.0915 | 0.0740.0860.090 |
症状 | 轻(+) | 中(++) | 重(+++) |
腰膝酸痛性功能低下精神不振夜尿频多 | 偶有发作***降低精神不振夜尿1-2次 | 反复发作偶有性要求精神萎靡夜尿3-4次 | 持续发作,不易缓解阳萎或宫寒***精神萎靡,反应迟钝夜尿频,次数很多 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100691311A CN1323700C (zh) | 2004-07-06 | 2004-07-06 | 一种治疗虚损病的中药组合物及其制备方法和质量标准 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100691311A CN1323700C (zh) | 2004-07-06 | 2004-07-06 | 一种治疗虚损病的中药组合物及其制备方法和质量标准 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1718206A CN1718206A (zh) | 2006-01-11 |
CN1323700C true CN1323700C (zh) | 2007-07-04 |
Family
ID=35930235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100691311A Expired - Fee Related CN1323700C (zh) | 2004-07-06 | 2004-07-06 | 一种治疗虚损病的中药组合物及其制备方法和质量标准 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1323700C (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102018859A (zh) * | 2010-12-14 | 2011-04-20 | 吴剑生 | 一种中药组合物的制备方法 |
CN106913744A (zh) * | 2016-12-02 | 2017-07-04 | 广东心宝药业科技有限公司 | 补肾中药组合物及其制备方法 |
CN107412510B (zh) * | 2017-04-28 | 2018-04-03 | 广东心宝药业科技有限公司 | 一种具有阴阳并补作用的中药组合物及其制备方法 |
CN114306491B (zh) * | 2021-12-22 | 2023-02-28 | 江苏七○七天然制药有限公司 | 一种首乌生发胶囊及其制备、检测和成分鉴别方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1365808A (zh) * | 2001-01-18 | 2002-08-28 | 杨孟君 | 纳米龟鹿补肾制剂药物及其制备方法 |
-
2004
- 2004-07-06 CN CNB2004100691311A patent/CN1323700C/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1365808A (zh) * | 2001-01-18 | 2002-08-28 | 杨孟君 | 纳米龟鹿补肾制剂药物及其制备方法 |
Non-Patent Citations (1)
Title |
---|
龟鹿补肾胶囊 部药品标准(中药成方制剂第十七册) 1998 * |
Also Published As
Publication number | Publication date |
---|---|
CN1718206A (zh) | 2006-01-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1895617A (zh) | 温肾养心、壮腰安神的中药制剂及制备方法和质量控制方法 | |
CN1857642A (zh) | 一种解郁安神制剂的质量控制方法 | |
CN1876089A (zh) | 一种治疗肾气虚证的药物组合物及其制备方法 | |
CN1323700C (zh) | 一种治疗虚损病的中药组合物及其制备方法和质量标准 | |
CN1709341A (zh) | 一种益气健脾的药物组合物及其制备方法和用途 | |
CN1907481A (zh) | 一种治疗暑湿感冒的药物组合物及其制备工艺 | |
CN1872199A (zh) | 一种中药组合物及其制备方法 | |
CN1255100C (zh) | 藏药独一味软胶囊制剂及其制备方法 | |
CN1919272A (zh) | 一种中药浓缩丸 | |
CN1785220A (zh) | 补血当归制剂的质量控制方法 | |
CN1907436A (zh) | 一种治疗小儿厌食的药物组合物及其制备工艺 | |
CN1814129A (zh) | 一种复方乌鸡片剂及其制备方法质量控制方法 | |
CN1785347A (zh) | 一种小儿高热不退的中药制剂质量控制方法 | |
CN1883674A (zh) | 治疗糖尿病的降糖宁制剂及其制备方法 | |
CN1857588A (zh) | 一种仙灵骨葆制剂的质量控制方法 | |
CN1220519C (zh) | 治疗***癌的中药组合物及其制备方法和制药应用 | |
CN1291734C (zh) | 一种中药软胶囊制剂的质量控制方法 | |
CN1548138A (zh) | 一种治疗虚损病的中药组合物及其质量控制方法 | |
CN1824082A (zh) | 金地蓝解毒药物组合物、制剂及制备方法 | |
CN1286488C (zh) | 黄连、吴茱萸总生物碱的提取方法 | |
CN1258372C (zh) | 治疗肠易激综合症的中药组合物及其制备方法 | |
CN1857580A (zh) | 补脾益肾制剂及其制备方法与检验方法 | |
CN1857592A (zh) | 一种跌打红药制剂的质量控制方法 | |
CN1907321A (zh) | 一种治疗表虚不固的药物组合物及其制备工艺 | |
CN1267117C (zh) | 一种治疗跌打损伤、胸胁疼痛的药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: GUANGDONG BAOSHANTANG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: WU SHAOHUI Effective date: 20101209 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 515556 BAOSHAN, YUNLU, JIEDONG COUNTY, GUANGDONG PROVINCE TO: 515500 GREEN INDUSTRIAL PARK, DEVELOPMENT ZONE, JIEDONG, GUANGDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20101209 Address after: 515500 green industrial zone, Jiedong Development Zone, Guangdong Patentee after: Guandong Baoshantang Pharmaceutical Co., Ltd. Address before: Guangdong County of Jiedong province Baoshan 515556 cloud Patentee before: Wu Shaohui |
|
ASS | Succession or assignment of patent right |
Owner name: GUANGDONG SHIXIN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: GUANGDONG BAOSHANTANG PHARMACEUTICAL CO., LTD. Effective date: 20140730 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20140730 Address after: 515500 green industrial zone, Jiedong Development Zone, Jiedong District, Guangdong, Jieyang Patentee after: Guangdong Shixin medcine Co., Ltd. Address before: 515500 green industrial zone, Jiedong Development Zone, Guangdong Patentee before: Guandong Baoshantang Pharmaceutical Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070704 Termination date: 20150706 |
|
EXPY | Termination of patent right or utility model |